As insiders continue to exercise options on the stock, the number of shares outstanding continues to grow. I am frustrated with Spectrum's management in this regard. I have been a long since September, and the stock has done nothing but stay flat and nothing budges it past 13.
Here's a question I have: Why do executives continue to exercise options if there is so much potential for the share price to rise massively in a short time-span?
Another question: While Raj has said he believes Fusilev sales will grow in 2013, he has not given any meaningful guidance in this regard. I feel frustrated with my investment in Spectrum while the rest of the market reaches new highs whie it lags in a completely flat zone. There is diminishing volume and the earnings continue to disappoint the market.
I believe that the pipeline is undervalued and that the market has over-estimated the decline in Fusilev, especially given its potential use with folotyn, but the company needs to do something. It's been six months.
Patience, my friend!
Take a look at the 5 year chart: from sept 09 to about nov 10 -over a year- we were range bound in the 4's. None of us who bought back then have any regrets now, although it was frustrating at the time. Have faith in the fundamentals. I am firm believer that this is a solid long term investment - in that respect, I'm happy to see it remain undervalued: I get my tax return in a week or so, the current price just means I'll get to pick up more shares than I expected to!